Simultaneous determination of all-trans and 13-cis retinoic acids and their 4-oxo metabolites by adsorption liquid chromatography after solid-phase extraction.
All-trans retinoic acid (all-trans RA), the active metabolite of vitamin A, has been demonstrated to be an efficient alternative to chemotherapy in the treatment of acute promyelocytic leukemia (APL), the AML3 subtype of the FAB cytological classification. Complete remission is obtained by inducing terminal granulocytic differentiation of the leukemic cells. To study all-trans RA pharmacokinetics in patients with APL, a rapid, precise and selective high-performance liquid chromatographic (HPLC) assay was developed. This method is easy and shows good repeatability (C.V. = 8.41-12.44%), reproducibility (C.V. = 9.19-14.73%), accuracy (C.V. = 3.5-11%) and sensitivity with a detection limit of 5 pmol/ml. The analysis is performed using normal-phase HPLC in an isocratic mode with UV detection after solid-phase extraction on octadecyl (C18) columns. The mobile phase is hexane-dichloromethane-dioxane (78:18:4, v/v) containing 1% acetic acid.
Lefebvre
P
P
Laboratoire de Chimie Analytique, Faculté de Pharmacie, Université Paris V, France.
Agadir
A
A
Cornic
M
M
Gourmel
B
B
Hue
B
B
Dreux
C
C
Degos
L
L
Chomienne
C
C
D000327:Adsorption; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006801:Humans; D015474:Isotretinoin / Q000097:blood*; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood; D015203:Reproducibility of Results; D013056:Spectrophotometry, Ultraviolet; D014212:Tretinoin / Q000097:blood*
D014212:Tretinoin; D015474:Isotretinoin